As sudden cardiac death among patients with heart failure remains a major concern in the U.S., a new study conducted by researchers from Virginia Tech aims to tackle the issue.

A scientist from the University of Connecticut has created a technique to study heart tissues and identify heart disease. The method is similar to how physicians examine cancer tissue under a microscope.

Novartis has launched a social network called Together in HF for heart failure patients and caregivers.

Obesity is a major risk factor for cardiovascular disease. In order to treat it, physicians and patients must approach it like a cancer. 

Fruits and vegetables have been proven to protect against cardiovascular disease, but new research suggests that younger vegetable have a greater impact on lowering risks.  

Jardiance, a medication designed to reduce the risk of cardiovascular death in adults with type 2 diabetes and cardiovascular disease, was approved by the U.S. Food and Drug Administration (FDA) this week, making it the first type 2 diabetes treatment of its kind.

The Centers for Medicare and Medicaid Services (CMS) has approved a new specialty code for advanced heart failure and transplant cardiologists.

Patients with chronic heart failure who received omecantiv mecarbil achieved plasma concentrations associated with improved cardiac function and decreased ventricular function, according to a randomized trial.